These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 35247611)
1. Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway. Jiang B; Wang D; Hu Y; Li W; Liu F; Zhu X; Li X; Zhang H; Bai H; Yang Q; Yang X; Ben J; Chen Q Mol Metab; 2022 May; 59():101462. PubMed ID: 35247611 [TBL] [Abstract][Full Text] [Related]
2. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway. Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893 [TBL] [Abstract][Full Text] [Related]
3. ADAR2 deficiency ameliorates non-alcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1. Kung ML; Yang TH; Lin CC; Ho JY; Hung TC; Chang CH; Huang KW; Chen CC; Chen YW J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):949-962. PubMed ID: 38533529 [TBL] [Abstract][Full Text] [Related]
4. Alternate-day fasting protects the livers of mice against high-fat diet-induced inflammation associated with the suppression of Toll-like receptor 4/nuclear factor κB signaling. Yang W; Cao M; Mao X; Wei X; Li X; Chen G; Zhang J; Wang Z; Shi J; Huang H; Yao X; Liu C Nutr Res; 2016 Jun; 36(6):586-93. PubMed ID: 27188904 [TBL] [Abstract][Full Text] [Related]
5. Hepatocytes derived increased SAA1 promotes intrahepatic platelet aggregation and aggravates liver inflammation in NAFLD. Li D; Xie P; Zhao S; Zhao J; Yao Y; Zhao Y; Ren G; Liu X Biochem Biophys Res Commun; 2021 May; 555():54-60. PubMed ID: 33813276 [TBL] [Abstract][Full Text] [Related]
6. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress. Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260 [TBL] [Abstract][Full Text] [Related]
7. Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4/NF-κB/NLRP3 pathway. Yan BF; Wang Y; Wang WB; Ding XJ; Wei B; Liu SJ; Fu TM; Chen L; Zhang JZ; Liu J; Zheng X J Ethnopharmacol; 2023 Mar; 303():115999. PubMed ID: 36509260 [TBL] [Abstract][Full Text] [Related]
8. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861 [TBL] [Abstract][Full Text] [Related]
9. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling. He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523 [TBL] [Abstract][Full Text] [Related]
10. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1. Wu L; Liu Y; Zhao Y; Li M; Guo L Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490 [TBL] [Abstract][Full Text] [Related]
11. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder. Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955 [No Abstract] [Full Text] [Related]
12. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356 [TBL] [Abstract][Full Text] [Related]
13. Silencing of SAA1 inhibits palmitate- or high-fat diet induced insulin resistance through suppression of the NF-κB pathway. Wang Y; Cao F; Wang Y; Yu G; Jia BL Mol Med; 2019 May; 25(1):17. PubMed ID: 31060494 [TBL] [Abstract][Full Text] [Related]
14. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway. Ye M; Tang Y; He J; Yang Y; Cao X; Kou S; Wang L; Sheng L; Xue J Clin Investig Arterioscler; 2021; 33(5):257-266. PubMed ID: 33810882 [TBL] [Abstract][Full Text] [Related]
15. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642 [TBL] [Abstract][Full Text] [Related]
16. WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling. Jung TW; Kang C; Goh J; Chae SI; Kim HC; Lee TJ; Abd El-Aty AM; Jeong JH J Cell Physiol; 2018 Aug; 233(8):6077-6087. PubMed ID: 29319180 [TBL] [Abstract][Full Text] [Related]
17. PREX1 depletion ameliorates high-fat diet-induced non-alcoholic fatty liver disease in mice and mitigates palmitic acid-induced hepatocellular injury via suppressing the NF-κB signaling pathway. Li Z; Wu K; Zou Y; Gong W; Wang P; Wang H Toxicol Appl Pharmacol; 2022 Aug; 448():116074. PubMed ID: 35605788 [TBL] [Abstract][Full Text] [Related]
18. MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF- Hu J; Du H; Yuan Y; Guo P; Yang J; Yin X; Liu J; Wu S; Wan J; Gong X Mediators Inflamm; 2022; 2022():5791915. PubMed ID: 35769208 [TBL] [Abstract][Full Text] [Related]
19. The capsaicinoid nonivamide suppresses the inflammatory response and attenuates the progression of steatosis in a NAFLD-rat model. Wikan N; Tocharus J; Oka C; Sivasinprasasn S; Chaichompoo W; Suksamrarn A; Tocharus C J Biochem Mol Toxicol; 2023 Mar; 37(3):e23279. PubMed ID: 36541345 [TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A1 mediates myotube atrophy via Toll-like receptors. Hahn A; Kny M; Pablo-Tortola C; Todiras M; Willenbrock M; Schmidt S; Schmoeckel K; Jorde I; Nowak M; Jarosch E; Sommer T; Bröker BM; Felix SB; Scheidereit C; Weber-Carstens S; Butter C; Luft FC; Fielitz J J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):103-119. PubMed ID: 31441598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]